← Back to Clinical Trials
Recruiting NCT07430943

NCT07430943 Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07430943
Status Recruiting
Phase —
Sponsor Mona Lichtblau
Condition Pulmonary Rehabilitation
Study Type INTERVENTIONAL
Enrollment 12 participants
Start Date 2026-03-05
Primary Completion 2027-02-28

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Street Racket

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 12 participants in total. It began in 2026-03-05 with a primary completion date of 2027-02-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study looks at whether Street Racket is a feasable activity that can be added to pulmonary rehabilitation for people with chronic lung disease. Participants complete short questionnaires at the start and end of the program to rate the feasibility and rate their breathlessness during each session. Attendance is recorded to understand how well the activity is used and whether there are any barriers.

Eligibility Criteria

Inclusion Criteria: * Any sex or gender * Age \>18 years * Prescribed APR by a physician and currently participating in APR at the USZ * Physically and psychologically capable of following instructions and standing/walking for up to one hour (short, seated breaks are allowed if needed) Exclusion Criteria: * Require supplemental oxygen therapy that cannot be delivered via a portable backpack system (e.g., large oxygen cylinders on wheels, which pose a fall risk) * Are unable to follow study procedures due to language barriers, psychological conditions, or orthopaedic limitations that prevent them from standing or walking for up to one hour * Require walking aids due to impaired balance (e.g., walking sticks, rollator, etc.)

Contact & Investigator

Central Contact

Mona Lichtblau, PD Dr. med.

✉ mona.lichtblau@usz.ch

📞 +41 442552220

Principal Investigator

Mona Lichtblau

PRINCIPAL INVESTIGATOR

University of Zurich

Frequently Asked Questions

Who can join the NCT07430943 clinical trial?

This trial is open to participants of all sexes, studying Pulmonary Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07430943 currently recruiting?

Yes, NCT07430943 is actively recruiting participants. Contact the research team at mona.lichtblau@usz.ch for enrollment information.

Where is the NCT07430943 trial being conducted?

This trial is being conducted at Zurich, Switzerland, Zurich, Switzerland.

Who is sponsoring the NCT07430943 clinical trial?

NCT07430943 is sponsored by Mona Lichtblau. The principal investigator is Mona Lichtblau at University of Zurich. The trial plans to enroll 12 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology